Comparison of the efficacy of sucroferric oxyhydroxide and lanthanum carbonate in the hyperphosphatemia of maintainable Hemodialysis
SFOH was superior to LC in lowering patients' blood phosphorus and iPTH levels in patients with maintenance hemodialysis hyperphosphatemia combined with secondary hyperparathyroidism.
Authors
- Yu-Qing Kang
- X Ni (ORCID: https://orcid.org/0009-0006-3775-8220)
- Min Li (ORCID: https://orcid.org/0009-0003-9757-6822)
- Chao Zhang (ORCID: https://orcid.org/0000-0002-9989-6462)
Institutions
- Taian City Central Hospital (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1186/s40360-025-00914-2
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00